Sign in
The Conundrum of Intravitreal Injections and Use of -25 Modifier for Same-Day Office Visits
John T. Thompson, MD
Annual Meeting Talks
2021
Uncertain Benefit of Vitrectomy for Post-Injection Endophthalmitis in Age-Related Macular Degeneration
Mark R. Barakat, MD
On Demand Cases, Courses, and Papers
2017
Noninferiority of 1.7% Povidone–Iodine for Endophthalmitis Prophylaxis After Intravitreal Injections Compared With 5% Povidone–Iodine in an Office Setting
Kamal Kishore, MD, MBBS
2022
Category: Socioeconomics